On June 12, 2026, SpaceX held the largest IPO in history: $75 billion in capital raised, a valuation of approximately $1.75 trillion, and debuted on the Nasdaq under the ticker symbol SPCX. For a retail investor, it looked like a rare chance to buy a stake in the world's most talked-about private company for the first time in two decades. On the first day, the security added 19%, and by June 16 it reached a peak above $225.
It's in these moments of euphoria that the worst investment decisions are made. Behind the big narrative lies a set of structural factors that make buying SpaceX at its IPO one of the least profitable entry points into this asset. It's not about the quality of the company itself - Starlink is profitable, and its technological leadership is undeniable. It's about the price, the shortage of supply and the schedule according to which this supply will enter the market over the next 12 months.
Let's look at five reasons why an IPO entry in 2026 is an entry at its peak, and why SpaceX's real pricing won't begin until closer to the summer of 2027
1. The price is distorted by microscopic free-float.
At the IPO, less than 5% of all SpaceX shares were publicly traded. At an offering price of $135, this gave a capitalization of about $1.75 trillion, but the first day closed at $160.95 (+19%), and on June 16 the security peaked above $225. This rise is a reflection of supply shortages rather than business valuation: the immediate post-IPO surges were driven by structural equity shortages rather than sustainable long-term valuations. When the float expands, the price will begin to seek a new equilibrium - usually lower.
2. The main block of shares is frozen for 366 days.
Musk and “significant investors” signed a lock-up for 366 calendar days without the right to early sale - they legally cannot sell a single share until June 13, 2027. At the same time, Musk controls about 82% of the votes through special voting shares. That is, the largest concentration of capital does not physically enter the market in the first year - and until this moment the market simply does not see a real offer from the main holders.
3. Early VCs and employees sell in waves - a constant canopy.
This is where the pressure of the first year lies. Pre-IPO investors have a 180-day lockup, but with the right to partially sell earlier - after a series of benchmarks, including quarterly reports. Employees have a stepped schedule: 20% after the Q2 report (late July - early August), then 7% tranches every two to four weeks from August to October, ~28% release after the Q3 report, and all remaining securities - December 8, 2026. An additional 10% bonus tranche is unlocked only if SPCX is trading at least 30% above the IPO price - that is ≥$175.50. Each such window is a potential wave of insider sales.
4. Valuation is divorced from fundamentals.
At the IPO, the company was valued at approximately 90-110 annual revenues in 2025 - a multiple of the level of an early software company, and not a capital-intensive launch-and-satellite business, which is still unprofitable. By comparison, Morningstar estimates a fair value of about $780 billion, less than half the IPO capitalization, and the company itself lost nearly $5 billion last year. The range of targets is huge: the average 12-month target is about $188 with a range from $62 to $310. While there is no consensus on the valuation, the price will be painful to find.
5. The index tailwind has been delayed and weakened.
The mechanical demand of passive funds, which could support the quote, does not work at full capacity in the first year. Because only about 5% of the shares are available to the public, float-adjustment gives SpaceX a weight of only ~1% in the index instead of 5%. And the S&P 500 opted out of accelerated inclusion on June 4, maintaining the requirement of 12-month maturity and GAAP profitability—that is, inclusion in the S&P no earlier than mid-2027. The result is an asymmetry: insiders begin to sell in the summer-autumn of 2026, and the main index demand comes later.
Real pricing will begin when the largest block is unfrozen - Musk and significant investors in June 2027 - and the market sees full supply versus demand for the first time. This is already evident from the dynamics: from a peak of $225.64 (June 16), the security dropped to ~$166 by June 22, and in the last session the fall was about 16%. Until the summer of 2027, the SPCX quote is largely a function of float scarcity and news background, rather than a sustainable business valuation.
What does this mean for the investor?
Buying such a company at the IPO is, in essence, entering at the peak of the narrative and at the most disadvantageous point in the supply cycle. The investor pays a multiple of 90-110 earnings for a business that is still unprofitable, capitalized at twice conservative fair value estimates, and assumes the full brunt of the next 12 months' shutdowns. The asymmetry here works against the late buyer: the upside has already been largely won back by the hype, and the downside is just beginning to reveal itself.
Structurally, the more interesting entry point is at the Pre-IPO stage, before this premium overhang is formed. Here the investor enters at the valuation of the early round, and the IPO itself becomes not an entry point, but an exit and liquidity point. It is in this window that the main growth potential is historically formed - those same X's that are already distributed among early holders on the public market.
AMCH gives access to exactly this stage: carefully selected companies with valuations above $1 billion, with a target exit horizon of about 2 years - through a secondary sale before an IPO or through the listing itself. The upside potential is a multiple, but it remains potential: access is structured through an SPV, investments involve risk, and returns are not guaranteed.